PATENT CLAIM ANALYSIS

Application Number: 16090385
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-02
Patent Classification: ["514", "326000"]

Abstract:
The present invention relates to piperidinylalkylamide derivatives having dual pharmacological activity towards both the sigma (σ) receptor and the μ-opioid receptor, to processes of preparation of such compounds, to pharmaceutical compositions comprising them, and to their use in therapy, in particular for the treatment of pain.

Claim (Index 18):
The compound according to  claim 13 , wherein R 2  is substituted or unsubstituted aryl.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 97.0
- Lexical Diversity: 1.325
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['16090403', '15746877', '15747220', '15531810', '15571352']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.809548119281927
- 35 USC 102 Novelty (BERT): 0.5821296343485617
- Combined Prediction Score: 0.7868062707885906
- Mean Citation Score: 445.959034
- Max Citation Score: 473.35364
- Similarity Product: 415.5775331951141

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test